Radiotherapy

Search with Google Search with Bing

Information
Drug Name
Radiotherapy
Description
Entry(CIViC)
CIViC
[No Data.]
Annotation
Description Associated Genes Associated Variants Sensitivity Supported Source Links
Radiolabeled MSH yielded quantitative therapeutic ... MC1R MC1R UNKNOWN Sensitivity true MMMP detail
Uveal melanoma. Amfenac increases the radiosensiti... PTGS2 PTGS2 UNDEREXPRESSION Sensitivity true MMMP detail
HDAC inhibitors radiosensitize human tumor cells b... HDAC9 HDAC9 UNDEREXPRESSION Sensitivity true MMMP detail
HDAC inhibitors radiosensitize human tumor cells b... HDAC9 HDAC9 UNDEREXPRESSION Sensitivity true MMMP detail
Dbait is a small molecule mimicking DNA damage (it... H2AX H2AX UNKNOWN Sensitivity true MMMP detail
Poly(I:C) is a toll like receptor (TLR) agonist TLR3 TLR3 OVEREXPRESSION Sensitivity true MMMP detail
PD184352 is a MEK inhibitor MAP2K7 MAP2K7 UNDEREXPRESSION Resitance or Non-Reponse true MMMP detail
STAT1-high tumor cells also demonstrate resistance... STAT1 STAT1 EXPRESSION Resitance or Non-Reponse true MMMP detail
Results were based on both expression and forced e... DCT DCT EXPRESSION Resitance or Non-Reponse true MMMP detail
Through its transcriptional activity, CREB plays a... CREB1 CREB1 UNDEREXPRESSION Sensitivity true MMMP detail
Cells were transfected with ATF2 cDNA lacking the ... ATF2 ATF2 UNDEREXPRESSION Sensitivity true MMMP detail
MYC downregulation sensitizes melanoma to radiatio... MYC MYC UNDEREXPRESSION Sensitivity true MMMP detail
Mcl-1 blocks radiation-induced apoptosis and inhib... MCL1 MCL1 UNDEREXPRESSION Sensitivity true MMMP detail
Unlike other malignancies, ATM does not modultate ... ATM ATM UNDEREXPRESSION Resitance or Non-Reponse true MMMP detail
c-Myc is able to sensitize human melanoma cells to... MYC MYC OVEREXPRESSION Sensitivity true MMMP detail
A morpholino oligonucleotide targeting CD47 (recep... CD47 CD47 UNDEREXPRESSION toxicity decrease true MMMP detail
NCT ID Status Phase Summary Start date Completion date
NCT01566240 Active, not recruiting Phase 3 Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer November 8, 2012 December 2026
NCT06342167 Active, not recruiting Phase 2 Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma March 14, 2024 December 1, 2026
NCT03605550 Active, not recruiting Phase 1 A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma August 1, 2018 March 1, 2029
NCT04304209 Active, not recruiting Phase 2 Pd1 Antibody Sintilimab ± Chemoradiotherapy for Locally Advanced Rectal Cancer October 28, 2019 October 18, 2026
NCT03181477 Active, not recruiting N/A Study Evaluating the Efficacy of Radiotherapy With SIB-IMRT, Associated With Temozolomide in Glioblastomas April 7, 2017 September 2, 2025
NCT05415215 Active, not recruiting Phase 3 A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer July 5, 2022 December 31, 2025
NCT03148327 Active, not recruiting Phase 1/Phase 2 Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body Radiotherapy October 11, 2017 June 1, 2025
NCT03385226 Active, not recruiting Phase 2 A Trial Assessing the Effect of Pembrolizumab Combined With Radiotherapy in Patients With Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS) January 15, 2019 September 2024
NCT03691441 Active, not recruiting Phase 4 Comparative Effectiveness Trial of Transoral Head and Neck Surgery Followed by Adjuvant Radio(Chemo)Therapy Versus Primary Radiochemotherapy for Oropharyngeal Cancer January 5, 2018 May 5, 2024
NCT02229656 Active, not recruiting Phase 1 Olaparib and Radiotherapy in Head and Neck Cancer September 24, 2014 January 2024
NCT03255252 Active, not recruiting Phase 2 Assessment Study to Evaluate Specific Immune Response in Locally Advanced Cervix Cancer After Radio-chemotherapy July 15, 2017 July 2024
NCT01957436 Active, not recruiting Phase 3 A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer November 13, 2013 December 2032
NCT03612791 Active, not recruiting Phase 2 Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab August 13, 2018 April 2025
NCT00407186 Active, not recruiting Phase 3 Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS) January 11, 2007 December 2025
NCT04324840 Active, not recruiting Phase 1 A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma July 10, 2020 May 15, 2026
NCT02799706 Active, not recruiting Phase 3 Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer September 25, 2017 June 2026
NCT03507010 Active, not recruiting Phase 3 Ledderhose Disease: Radiotherapy or Not? January 23, 2018 March 15, 2029
NCT03957590 Active, not recruiting Phase 3 Study of Tislelizumab (BGB-A317) Versus Placebo in Combination With Chemoradiotherapy in Participant With ESCC June 12, 2019 December 30, 2024
NCT04452032 Active, not recruiting Phase 2 Prospective Pilot Study Evaluating Dental Side Effects of Radiotherapy on Subjects Treated for Head and Neck Cancer November 17, 2020 May 16, 2027
NCT05868317 Active, not recruiting Phase 2 Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer November 1, 2020 November 30, 2023
NCT03620032 Active, not recruiting Phase 2 Study of Re-irradiation at Relapse Versus RT and Multiple Elective rt Courses November 2, 2015 November 2, 2024
NCT03532880 Active, not recruiting Phase 1 A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer July 12, 2018 June 2024
NCT02437071 Active, not recruiting Phase 2 Assess the Efficacy of Pembrolizumab Plus Radiotherapy or Ablation in Metastatic Colorectal Cancer Patients April 2015 April 2025
NCT02135679 Active, not recruiting The Detection Of Circulating Tumor Cells (CTC) In Patients With NSCLC Undergoing Definitive Radiotherapy Or Chemoradiotherapy September 2012 December 2023
NCT02918955 Active, not recruiting Phase 3 Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection October 2016 May 2025
NCT04062708 Active, not recruiting Phase 2 CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer March 10, 2021 June 2026
NCT05009069 Active, not recruiting Phase 2 A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer March 18, 2022 October 30, 2026
NCT04085250 Active, not recruiting Phase 2 Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy November 28, 2019 January 31, 2025
NCT02662062 Active, not recruiting Phase 2 Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer August 2016 January 2024
NCT05775068 Active, not recruiting ARtificial Intelligence for Gross Tumour vOlume Segmentation July 1, 2021 December 1, 2024
NCT03340896 Active, not recruiting Phase 3 Trial of Laryngeal Preservation Comparing Induced CT Followed by RT vs CT Concomitant to RT June 25, 2015 November 2028
NCT00887380 Active, not recruiting Phase 3 STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing) September 16, 2009 December 2024
NCT04942626 Active, not recruiting Phase 1 Capecitabine-based Chemoradiotherapy in Combination With the IL-1 Receptor Antagonist Anakinra for Rectal Cancer Patients August 20, 2021 December 31, 2025
NCT04503694 Active, not recruiting Phase 2 Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer March 25, 2021 January 2030
NCT03542175 Active, not recruiting Phase 1 A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy May 23, 2018 July 25, 2024
NCT04764227 Active, not recruiting Phase 2 Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17) May 30, 2020 March 30, 2027
NCT04116047 Active, not recruiting Phase 3 CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC) July 2015 December 2030
NCT04722263 Active, not recruiting Early Phase 1 Radiotherapy for Keloids December 1, 2020 December 2024
NCT04121455 Active, not recruiting Phase 1/Phase 2 Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients September 12, 2019 December 2024
NCT01590355 Active, not recruiting Phase 2 A Phase II Randomized Trial for Early-stage Squamous Cell Carcinoma of the Oropharynx: Radiotherapy vs Trans-oral Robotic Surgery (ORATOR) June 2012 September 2023
NCT02025036 Active, not recruiting Phase 3 Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous Cancer October 2014 April 1, 2025
NCT04643574 Active, not recruiting Phase 1 NeoTIL in Advanced Solid Tumors March 9, 2021 November 2027
NCT04599062 Active, not recruiting Phase 1/Phase 2 TVEC and Preop Radiation for Sarcoma (8 ml Dose) September 10, 2020 November 2024
NCT04210115 Active, not recruiting Phase 3 Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975) February 28, 2020 February 1, 2027
NCT03544736 Active, not recruiting Phase 1/Phase 2 Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC) April 26, 2018 December 31, 2040
NCT00352027 Completed Phase 2 Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma July 20, 2006 November 15, 2022
NCT00374985 Completed Phase 1/Phase 2 Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction October 2005 September 2013
NCT00375310 Completed Phase 1 Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer September 2006 November 2014
NCT00387127 Completed Phase 2 Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head And Neck Cancer November 2006 January 2014
NCT00389727 Completed Phase 2 Simultaneous Integrated Boost (SIB)- IMRT September 24, 2004 May 26, 2008
NCT00400426 Completed Phase 2 DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer November 2006 June 2012
NCT06428994 Completed Risk for Subsequent Osteoradionecrosis in A Transferred Fibula Flap in Head and Neck Cancer Patients Undergoing Segmental Mandibulectomy: a Cohort Study March 1, 2019 February 28, 2022
NCT00405405 Completed Phase 1 Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer December 2006 June 2010
NCT00423618 Completed Phase 3 Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma March 2006 December 31, 2018
NCT00426504 Completed N/A Radiation Therapy Using Helical Tomotherapy IMRT for Head and Neck Cancer November 2006 April 2012
NCT00430911 Completed Phase 3 Radiotherapy for Malignant Astrocytomas in the Elderly February 2001
NCT00462735 Completed Phase 2 Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer February 2007 October 2010
NCT00463060 Completed Phase 1/Phase 2 Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer January 2007 July 2014
NCT00490880 Completed Phase 2 Neoadjuvant Chemo (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiotherapy in Patients With Bladder Cancer November 2003 August 2004
NCT00496652 Completed Phase 3 DAHANCA 19: The Importance of the EGFr-inhibitor Zalutumumab for the Outcome After Curative Radiotherapy for HNSCC November 2007 November 2016
NCT00502463 Completed N/A Induction Chemotherapy Prior to Radio-immunotherapy in Head and Neck Cancer Stage III/IV - a Methodical Trial October 3, 2007 January 19, 2014
NCT00536458 Completed Phase 3 Treatment of Localized Low Grade Lymphomas March 1999 December 2006
NCT00544609 Completed Phase 1 Sorafenib and Radiotherapy in the Treatment of Invasive Bladder Cancer With Conservative Intent December 2007 May 2012
NCT00551525 Completed Phase 2 Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer April 2008 December 2016
NCT00556127 Completed Phase 2 Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma June 2002 September 2006
NCT06190652 Completed Real-world Experience of ICIs Plus Chemotherapy With or Without Radiotherapy for Advanced ESCC. October 13, 2018 December 4, 2023
NCT00590213 Completed Phase 4 Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX June 2003
NCT00590278 Completed Phase 2 A Phase-II Study Of TOMUDEX Plus Radiotherapy In Subject With Inoperable or Recurrent Rectal Cancer August 2002
NCT00609284 Completed Phase 3 Randomized Trial of Concomitant Chemotherapy in Patients With Locally Advanced HNSCC Treated by Radiotherapy-erbitux February 15, 2008 March 26, 2019
NCT00610272 Completed Phase 3 Optimization of Radiotherapy in Treatment of Painful Bone Metastasis January 2008 August 2012
NCT00626639 Completed Phase 1/Phase 2 A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent Chemotherapy July 2005 July 2015
NCT00639262 Completed Phase 1 Combination of Sorafenib and Radiation for Brain Metastases and Primary Brain Tumors March 2008 September 2012
NCT00667342 Completed Phase 2 A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma June 3, 2008 August 2017
NCT00684567 Completed Phase 2 Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED) September 27, 2005 October 31, 2007
NCT00686725 Completed Phase 4 Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572) June 24, 2008 September 28, 2011
NCT00689221 Completed Phase 3 Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status September 2008 August 2013
NCT00704639 Completed Phase 1/Phase 2 Chemoradiation Treatment for Head and Neck Cancer April 2008 December 2015
NCT00704808 Completed Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739) May 2006 December 2008
NCT00723827 Completed Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2) March 2008 September 2011
NCT00725010 Completed Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816) April 2007 April 2009
NCT00789763 Completed Phase 1 Phase I-II to Evaluate Efficacy/Safety of Sorafenib+Gemcitabine+Radiotherapy in Locally Advanced Pancreatic Carcinoma December 2007 January 2012
NCT00813943 Completed Phase 2 Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status March 2009 August 2013
NCT00821951 Completed Phase 1 Vorinostat in Combination With Palliative Radiotherapy for Patients With Non-Small Cell Lung Cancer May 2009 July 2012
NCT00828009 Completed Phase 2 BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery January 17, 2011 May 22, 2019
NCT00828672 Completed Phase 2 Neoadjuvant Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin Locally Advanced Rectal Cancer June 2009 March 2019
NCT00868491 Completed Phase 2 Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer March 2008 October 2011
NCT00003389 Completed Phase 3 Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma June 17, 1999 May 2016
NCT00888511 Completed Phase 2 Tarceva And Radiotherapy in Locally Advanced Lung Cancer Non-small Cell Lung Cancer May 2009 May 2016
NCT00909987 Completed Phase 2 Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer Rectum March 2009 June 2013
NCT00001189 Completed Phase 2 The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue Tumors December 1983 April 2001
NCT00949039 Completed Phase 3 Study Comparing Isolated Pelvic Perfusion With TNF-α 0.3 mg and Melphalan 1.5 mg/kg Versus Standard Treatment in Patients With Non Resectable, Recurrent Gynaecologic or Digestive Pelvic Cancer February 2009 March 2014
NCT00977431 Completed Phase 1 Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform September 17, 2009 September 12, 2017
NCT00983268 Completed Phase 1 Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer October 2009 February 2013
NCT05274945 Completed Phase 2 Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer January 1, 2020 January 1, 2022
NCT01011920 Completed Phase 2 Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma November 2009 March 2017
NCT01013779 Completed Phase 2 Merkel Positron Emission Tomography (PET) Protocol December 2009 June 2021
NCT05274594 Completed Efficacy of Preoperative Radiotherapy for Non-responder Patients After Neoadjuvant Chemotherapy January 1, 2017 January 1, 2022
NCT01029678 Completed Phase 2 Concomitant Radio-chemotherapy in the Elderly January 2010 June 2016
NCT05253144 Completed N/A Comparing Radical Surgery and Radical Radiotherapy as First Definitive Treatment for Primary MCC March 19, 2016 April 13, 2023
NCT01043536 Completed Phase 1 Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults September 2009
NCT01059188 Completed Phase 2 Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC) May 3, 2010 March 8, 2022
NCT01077999 Completed Phase 2 Chemoradiation and Panitumumab for Esophageal Cancer January 2010 April 2012
NCT01088347 Completed Phase 1/Phase 2 Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer March 2010 March 2014
NCT01102231 Completed Phase 2 Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC) March 2010 December 2015
NCT01122121 Completed Phase 3 Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate Cancer March 2000 June 2009
NCT01142778 Completed Phase 2 A Study of Bevacizumab Added to Trastuzumab Plus Docetaxel in the Neoadjuvant Setting in Participants With Early Stage HER2-Positive Breast Cancer May 19, 2010 December 13, 2017
NCT01145170 Completed Phase 2 Nimotuzumab and Radiotherapy in Pediatric Patients With Glioma March 2011 July 2014
NCT01166191 Completed Phase 2 Concurrent Chemo-radiotherapy With Intensity-Modulated Radiation Therapy (IMRT) for Limited Disease Small Cell Lung Cancer (LD-SCLC) May 2009 May 2017
NCT01166204 Completed Phase 2 Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone With Intensity-modulated Radiotherapy (IMRT) for Non Small Cell Lung Cancer (NSCLC) to an Individualised Mean Lung Dose (MLD) May 2009 May 2017
NCT00004660 Completed N/A Randomized Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy June 1993 January 1998
NCT01217060 Completed Phase 1/Phase 2 Trimodality Management of T1b Esophageal Cancers October 2010 June 14, 2020
NCT01249352 Completed Phase 2/Phase 3 A Study of Chemoradiation Associated With Nimotuzumab as the Treatment of Locally Advanced Esophageal Cancer January 2009 November 2013
NCT01262144 Completed SUV Max as Predictor of Outcome in Cervical Cancer August 2010
NCT01265849 Completed Phase 3 Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity December 2010 December 4, 2020
NCT01273051 Completed Phase 2 Transanal Endoscopic Microsurgery (TEM) After Radiochemotherapy for Rectal Cancer November 2010 August 2015
NCT01282450 Completed Phase 2 Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC) May 2006 July 2011
NCT04787523 Completed Rectrospect - a Retrospective Study of Treatment Response October 1, 2020 December 31, 2022
NCT01390948 Completed Phase 2 A Study of Bevacizumab (Avastin) in Combination With Temozolomide (TMZ) and Radiotherapy in Paediatric and Adolescent Participants With High-Grade Glioma October 18, 2011 January 29, 2020
NCT01413269 Completed Phase 3 Randomized Study of Hypofractionated and Conventional Fractionation Radiotherapy After Breast Conservative Surgery June 2010 September 2018
NCT01414738 Completed Phase 2 Hippocampal-Avoiding Whole Brain Irradiation With Simultaneous Integrated Boost for Treatment of Brain Metastases October 18, 2011 December 16, 2019
NCT01450449 Completed Phase 3 Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme February 2009 November 2014
NCT01467115 Completed Phase 2 Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck Cancer March 2010 October 7, 2014
NCT04551950 Completed Phase 1 Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046) October 19, 2020 June 30, 2022
NCT00525785 Completed Phase 2 Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) January 2004 January 2016
NCT03028766 Completed Phase 1 WEE1 Inhibitor With Cisplatin and Radiotherapy: A Trial in Head and Neck Cancer June 22, 2017 February 3, 2021
NCT03015077 Completed N/A Effects of Oral L-Glutamine in Head and Neck Cancer Patients During Radiotherapy July 2014 August 2016
NCT02825147 Completed Phase 2 Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma September 2013 July 2017
NCT02866383 Completed Phase 2 Immune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer or Biliary Tract Cancer Patients November 2016 November 30, 2022
NCT02869685 Completed N/A Consistency Analysis of PD-L1s in Advanced NSCLC Tissues and in Plasma Exosomes Before and After Radiotherapy July 1, 2017 August 30, 2019
NCT02876237 Completed N/A Geriatric Determinants of General Repercussion of Radiotherapy for Patient Over 75 Years With Prostate Cancer February 2015 August 2017
NCT02998619 Completed Radiotherapy of Pelvic Lymph Nodes in High Risk Prostate Cancer - A Retrospective Analysis December 2016 June 19, 2018
NCT02938273 Completed Phase 1 Bioimmunoradiotherapy (Cetuximab/RT/Avelumab) February 1, 2017 September 30, 2019
NCT02892708 Completed Phase 3 Impact of Surgery on the Treatment of Supratentorial Malignant Gliomas in Subjects Aged 70 and Over April 2008 April 2018
NCT02916511 Completed Phase 2 Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy Concurrent With Chemotherapy for Esophageal Squamous Cell Carcinoma September 1, 2016 July 1, 2023
NCT00101582 Completed Phase 3 Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer August 2005 August 2016
NCT00115700 Completed Phase 3 Radiotherapy Versus Radiotherapy Plus Chemotherapy in Early Stage Follicular Lymphoma February 2000 August 2018
NCT00117572 Completed Phase 3 Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE) November 2004 December 2016
NCT00122772 Completed Phase 3 CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy November 2005 June 2010
NCT00123318 Completed Phase 3 A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer February 2003 February 2012
NCT00126165 Completed Phase 1/Phase 2 Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer September 2004 August 2011
NCT00126555 Completed Phase 2 Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer March 2005 February 2013
NCT00138008 Completed Phase 3 Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy May 2004 May 2016
NCT00141648 Completed N/A Chemotherapy and Radiotherapy for Osteolymphoma September 2000 February 2008
NCT00153530 Completed Phase 4 Whole Brain Irradiation in Primary Central Nervous System (CNS) Lymphoma (PCNSL) May 2000 May 2009
NCT00154817 Completed Phase 2 A Phase II Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma (HCC) January 2002 May 2005
NCT00176254 Completed Phase 2 Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer May 2000 October 2012
NCT00176267 Completed Phase 2 Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer September 2002 January 31, 2017
NCT00191568 Completed Phase 2 Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer October 2002 May 2007
NCT00193882 Completed Phase 3 Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia. July 7, 2003 June 18, 2013
NCT00193895 Completed Phase 3 Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy for Cancer of the Head and Neck April 2005 March 31, 2016
NCT00193908 Completed Phase 3 Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine ("Sorbolene") Cream March 2004 October 2008
NCT00197444 Completed Phase 2 Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer January 2003 December 2008
NCT00210314 Completed Phase 2 Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma July 2003 December 2007
NCT00210379 Completed Phase 2 Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's Lymphoma November 2000 March 2007
NCT00214097 Completed Phase 1/Phase 2 Phase I/II Hypofractionated Radiotherapy for Prostate Cancer October 14, 2002 August 21, 2017
NCT00214136 Completed Phase 2 Intensity Modulated Radiation Therapy (IMRT) Radiotherapy for Treating Prostate Pelvic Nodes March 2005 March 2016
NCT00225784 Completed Phase 2 Cetuximab, Radiotherapy and Twice Weekly Gemcitabine to Treat Pancreatic Cancer February 2005 September 2012
NCT00229723 Completed Phase 2 IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma November 2004 June 2008
NCT00238407 Completed Phase 2 Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery March 2004 August 2010
NCT00239304 Completed Phase 1/Phase 2 Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck Cancer June 2003 March 2006
NCT00263029 Completed Phase 2 Preoperative Radiotherapy/ Oxaliplatin/ Capecitabine Treatment For Unresectable Locally-advanced Rectal Cancer June 2002
NCT00270790 Completed Phase 2 EVALUATION OF AMIFOSTINE FOR MUCOSAL AND HEMOPOETIC PROTECTION AND CARBOPLATIN, TAXOL, RADIOTHERAPY IN THE MANAGEMENT OF PATIENTS WITH HEAD AND NECK CANCER.(GCC 0202) May 2002 February 2009
NCT00287196 Completed Phase 3 Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph Nodes March 2002 December 2011
NCT00316888 Completed Phase 2 Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer February 28, 2007 August 17, 2021
NCT00318890 Completed Phase 1/Phase 2 Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck October 2002 December 2007
NCT00323115 Completed Phase 2 Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme May 2006 July 2013
NCT00334594 Completed Phase 2 Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma November 14, 2005 January 23, 2018
NCT00338039 Completed Phase 2 Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients September 2005 June 2011
NCT00094861 Completed Phase 2 Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC) January 2005 January 2014
NCT03426891 Completed Phase 1 Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma March 16, 2018 June 28, 2023
NCT03406468 Completed Phase 2 Re-Induction After Initial Response With Immune Therapy With Radiotherapy in Lung Cancer July 15, 2019 March 1, 2023
NCT03390608 Completed Prognostic and Predictive Factors for Small Breast Tumors January 1, 1977 July 30, 2016
NCT03388372 Completed Phase 2 Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma August 18, 2010 March 23, 2017
NCT03349710 Completed Phase 3 Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer December 15, 2017 October 14, 2019
NCT02567799 Completed Phase 1/Phase 2 BIO 300 Non-Small Cell Lung Cancer Study November 2015 September 2020
NCT03348722 Completed Active Surveillance or Radical Treatment for Newly Diagnosed Patients With a Localized, Low Risk, Prostate Cancer START May 15, 2015 March 1, 2023
NCT02587455 Completed Phase 1 Pembrolizumab and Palliative Radiotherapy in Lung June 24, 2016 August 20, 2021
NCT02591784 Completed Phase 2 Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer November 2008 December 2011
NCT03345095 Completed Phase 3 A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma July 26, 2018 June 30, 2023
NCT03330249 Completed Phase 2 Comparison of Two Concomitant Administration of RT With Cisplatin in Standard Infusion or Fractional Infusion December 3, 2015 May 10, 2021
NCT03322384 Completed Phase 1/Phase 2 UCDCC#271: Phase I/II Trial of Epacadostat, Intralesional SD101, Radiotherapy in Patients With Lymphoma January 17, 2018 April 8, 2020
NCT02607982 Completed Phase 2 CCRT for Esophageal Cancer. January 2005 November 2015
NCT02617589 Completed Phase 3 An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer) March 1, 2016 March 4, 2022
NCT03299660 Completed Phase 2 Avelumab With Chemoradiation in Locally Advanced Rectal Cancer April 30, 2018 February 28, 2023
NCT03298893 Completed Phase 1/Phase 2 Nivolumab in Association With Radiotherapy and Cisplatin in Locally Advanced Cervical Cancers Followed by Adjuvant Nivolumab for up to 6 Months November 27, 2017 March 7, 2022
NCT00099086 Completed Phase 1 Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer January 16, 2007 December 13, 2023
NCT02639026 Completed Phase 1 Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers January 26, 2016 June 27, 2023
NCT02644408 Completed Phase 3 Megestrol Acetate for the Improvement of Quality of Life in Esophageal Cancer With Chemoradiotherapy October 1, 2014 December 1, 2020
NCT02659540 Completed Phase 1 Pilot Study of the Safety/Efficacy of Combination Checkpoint Blockade + External Beam Radiotherapy in Stage IV Melanoma October 13, 2016 July 27, 2020
NCT02667587 Completed Phase 3 An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer) May 9, 2016 April 9, 2024
NCT02677155 Completed Phase 2 Sequential Intranodal Immunotherapy (SIIT) Combined With Anti-PD1 (Pembrolizumab) in Follicular Lymphoma January 2016 February 2021
NCT03224871 Completed Early Phase 1 UCDCC#269: A Pilot Study of Interlesional IL-2 and RT in Patients With NSCLC. August 11, 2017 January 10, 2020
NCT02707588 Completed Phase 2 Tolerance and Efficacy of Pembrolizumab or Cetuximab Combined With RT in Patients With Locally Advanced HNSCC May 18, 2016 October 17, 2022
NCT02709720 Completed Phase 2 Study of Vinorelbine and Cisplatin as Induction Therapy With Radiotherapy in Patients With Unresectable NSCLC April 15, 2016 December 16, 2019
NCT02716467 Completed N/A Effect of Intercessory Prayer in Patients With Breast Cancer in Radiotherapy Treatment: Clinical Trial April 2015 May 15, 2016
NCT03211442 Completed Implications of MEDIcal Low Dose RADiation Exposure - BReast Cancer Acute Coronary Events August 1, 2017 June 1, 2022
NCT02723253 Completed Phase 2 Concurrent Chemoradiation With Concomitant Boost In Locally Advanced Rectal Cancer January 2005 February 2012
NCT02730130 Completed Phase 2 Study to Assess the Efficacy of Pembrolizumab Plus Radiotherapy in Metastatic Triple Negative Breast Cancer Patients June 3, 2016 October 12, 2022
NCT02733458 Completed N/A GELAD Chemotherapy and Sandwiched Radiotherapy in the Treatment of Stage IE/IIE Natural Killer/T-cell Lymphoma March 2016 April 2021
NCT02735239 Completed Phase 1/Phase 2 Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer June 24, 2016 June 16, 2022
NCT03175939 Completed Phase 2 Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma April 1, 1998 December 31, 2014
NCT03113851 Completed Phase 2 Abscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung Cancer August 14, 2017 October 14, 2018
NCT03082144 Completed Phase 2 Concurrent Involved-field Radiotherapy and Intrathecal Chemotherapy for Leptomeningeal Metastases From Solid Tumors February 1, 2017 December 30, 2018
NCT03074175 Completed N/A Plasma miRNAs Predict Radiosensitivity of Different Fractionation Regimes in Palliative Radiotherapy for Advanced Non-small Cell Lung Cancer：Multicenter Controlled Study.(RadmiR-01) July 1, 2017 December 31, 2019
NCT03044626 Completed Phase 2 Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC February 10, 2017 December 31, 2020
NCT02784652 Completed Phase 2 Efficacy of Radiotherapy in Combination With Zoledronic Acid in Bone Metastasis Patients With Gastrointestinal Tumors June 2014 February 28, 2017
NCT02799238 Completed Phase 2 Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma March 2016 February 24, 2020
NCT01496001 Completed N/A Cosmetic and Functional Outcomes After Breast Conserving Surgery March 2011 January 2015
NCT04360993 Completed Role of PET/MRI in Head and Neck Cancer April 12, 2016 January 22, 2020
NCT01525953 Completed Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis January 2012 January 2012
NCT01537991 Completed N/A ISoToxic Accelerated RadioTherapy in Locally Advanced Non-small Cell Lung Cancer: The Phase I/II I-START Trial January 26, 2012 December 31, 2018
NCT01540682 Completed Phase 1 MLN8237 in Head and Neck Cancer February 2012
NCT01554059 Completed Phase 2 Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients March 2012 August 2014
NCT04229147 Completed Ledderhose Disease - Long Term Effects of Radiotherapy Treatment. LedRad LTE - Study May 13, 2019 January 31, 2020
NCT01602588 Completed Phase 2 A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG) May 2013 November 2017
NCT01614132 Completed Phase 1/Phase 2 Multicenter Pilot-study for the Therapy of Medulloblastoma of Adults January 2009 October 2018
NCT01621217 Completed Phase 1 Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (>4 cm) - T4 N0-3 M0 or Any T N2-3 M0 June 2012 January 2020
NCT04207918 Completed Phase 2 A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer November 14, 2019 June 30, 2023
NCT00004867 Completed N/A Positron Emission Tomography in Determining Stage of Esophageal Cancer November 1999 January 2009
NCT01663259 Completed N/A Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients January 2011 September 2019
NCT01676428 Completed N/A A Pilot Study of Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney or Isolated Adrenal Metastases May 2012 November 2015
NCT01687439 Completed Phase 2 Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC) December 2008 October 2009
NCT01696669 Completed Phase 2 Study of Intensive Chemotherapy, Surgery and Radiotherapy to Treat Ewing's Sarcoma in Children and Young Adults March 30, 2010 January 18, 2018
NCT01711242 Completed Phase 2 Trial of Adjuvant XELOX Chemotherapy and Concurrent Capecitabine and Radiotherapy for Resected Gastric Carcinoma January 2012 January 2021
NCT01737008 Completed Phase 1 Dacomitinib Plus Radiotherapy, With and Without Cisplatin in Patients With Squamous Cell Carcinoma of the Head and Neck January 2013 May 2015
NCT01787006 Completed Phase 2 Definitive Radiochemotherapy Plus/Minus Cetuximab in Unresectable Locally Advanced Esophageal Cancer September 2011 September 6, 2018
NCT01841047 Completed N/A Assessment of Helical Tomotherapy Radiotherapy (54 Gy) Followed by Surgery in Retro-peritoneal Liposarcoma January 20, 2009 December 19, 2018
NCT04072718 Completed Phase 2 Simultaneous Integrated Boost With Volumetric Arc Radiotherapy in Patients With Breast Cancer August 10, 2017 March 31, 2020
NCT03961217 Completed Return to Work Among Cancer Survivors With Treatment-induced Survivorship Syndromes January 1991 December 2016
NCT01860638 Completed Phase 2 A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With Glioblastoma August 19, 2013 May 5, 2017
NCT03958721 Completed Phase 1 Capecitabine and Radiotherapy in the Adjuvant Treatment of Resistant Breast Cancer July 18, 2019 October 26, 2023
NCT03916510 Completed Phase 1 Chemoradiation With Enadenotucirev as a Radiosensitiser in Locally Advanced Rectal Cancer July 1, 2019 February 24, 2023
NCT01915693 Completed Phase 3 ROCS (Radiotherapy After Oesophageal Cancer Stenting) Study October 2013 November 2018
NCT01918124 Completed Phase 2 A Phase II Trial of Adjuvant Radiotherapy Combined With Chemotherapy for Patients With High-risk Endometrial Cancer January 2008 January 2014
NCT01941966 Completed Phase 2 A Study of Substitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal. November 2010
NCT01950689 Completed Phase 3 NIMRAD (A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab) September 11, 2014 January 7, 2021
NCT03783364 Completed N/A Pre- or Postoperative Accelerated Radiotherapy September 17, 2018 November 19, 2021
NCT01989000 Completed N/A The Role of the Tumor Microenvironment of Pancreatic Cancer to Predict Treatment Outcome November 2013 December 2017
NCT01991808 Completed N/A Suitability of DCE-MRI for Detection of Vascular Changes After VBT October 2013 December 8, 2016
NCT03776071 Completed Phase 3 A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1 December 16, 2020 February 29, 2024
NCT03724890 Completed Phase 1 Study of Avelumab-M3814 Combinations November 27, 2018 August 17, 2022
NCT02022098 Completed N/A Debio 1143-201 Dose-finding and Efficacy Phase I/II Trial October 2013 April 28, 2022
NCT02024035 Completed Protocole Advanced RadioTherapy ORL November 2009 November 2013
NCT02029573 Completed Phase 2 Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma January 1, 2014 December 31, 2016
NCT03641547 Completed Phase 1 M6620 Plus Standard Treatment in Oesophageal and Other Cancer December 4, 2018 April 4, 2022
NCT02072148 Completed N/A The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL) March 2014 May 12, 2022
NCT00026871 Completed Phase 1 Clinical Evaluation of a Laser Heated, Fiberoptic-Coupled Radiation Dose Verification System July 1997 May 2006
NCT02107235 Completed Phase 1 Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer January 2014 January 2015
NCT03624231 Completed Phase 2 Feasibility & Efficacy of Durvalumab+Tremelimumab+RT and Durvalumab+RT in Non-resect. Locally Advanced HPVnegativ HNSCC August 15, 2018 August 17, 2023
NCT00026936 Completed Phase 2 A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning May 1999 January 2005
NCT02135653 Completed A Feasibility Study Followed By A Randomized Phase II Study Of Yoga For Radiation Therapy Side Effects In Prostate Cancer March 2013 December 2019
NCT02189473 Completed N/A Radiotherapy of Motor Deficits From Metastatic Epidural Spinal Cord Compression July 2010 July 2015
NCT03610061 Completed Phase 1 A Trial of Radiotherapy and Durvalumab in DLBCL and FL November 1, 2018 April 8, 2024
NCT00030771 Completed Phase 3 Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients April 4, 2001 September 15, 2023
NCT02227082 Completed Phase 1 Olaparib and Radiotherapy in Inoperable Breast Cancer October 21, 2013 August 2020
NCT00047710 Completed Phase 1 Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer September 2002 July 2006
NCT03600831 Completed Phase 2/Phase 3 Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma August 20, 2018 December 31, 2023
NCT02303990 Completed Phase 1 RADVAX: A Stratified Phase I Trial of Pembrolizumab With Hypofractionated Radiotherapy in Patients With Advanced and Metastatic Cancers January 8, 2015 December 31, 2019
NCT03565029 Completed Phase 2 Total Neoadjuvant Treatment Without Surgery For Locally Advanced Rectal Cancer June 1, 2018 December 31, 2022
NCT02353858 Completed Phase 2 Preoperative Radiochemotherapy With Hyperthermia for Locally Advanced Rectal Cancer August 2012 December 2017
NCT02364206 Completed Phase 1/Phase 2 Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma June 8, 2015 August 2019
NCT02376322 Completed Phase 2 Hypofractionated Radiotherapy (16/2) for the Palliation of Complicated Bone Metastases in Patients With KPS July 2014 July 30, 2016
NCT02378532 Completed Phase 1 The Addition of Chloroquine to Chemoradiation for Glioblastoma August 2016 July 30, 2019
NCT02383498 Completed Phase 2 QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma May 1, 2015 September 1, 2019
NCT02394132 Completed Phase 3 Radiotherapy or Imiquimod in Complex Lentigo Maligna August 31, 2015 March 30, 2023
NCT02399306 Completed Phase 3 Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma September 2014 October 2017
NCT02403531 Completed Phase 2 Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal Cancer May 1, 2015 May 30, 2020
NCT03538223 Completed N/A Music Listening in Radiotherapy Treatment March 5, 2018 September 30, 2020
NCT00068692 Completed Phase 3 Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer October 15, 2003 November 15, 2016
NCT02423889 Completed Phase 2 Stereotactic Volumetric Radiotherapy in Prostate Cancer April 2013
NCT02443493 Completed N/A Laser Therapy for the Prevention of Radiodermatitis in Breast Cancer Patients April 2015 June 2017
NCT02453191 Completed Phase 1/Phase 2 TVEC and Preop Radiation for Sarcoma (4 ml Dose) July 13, 2015 March 10, 2023
NCT00070616 Completed Phase 1 Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support December 2001 March 2005
NCT02459457 Completed Phase 3 A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer July 1, 2015 February 2022
NCT03507244 Completed Phase 1/Phase 2 Concurrent Intrathecal-pemetrexed and Involved-field Radiotherapy for Leptomeningeal Metastasis From Solid Tumors April 12, 2018 July 30, 2019
NCT02471079 Completed TOxicity After Radiotherapy in breAst CancEr Survivors (ThORACeS) - A Retrospective Cohort Study September 2014 September 2015
NCT03453892 Completed Investigation of the Timely-coordinated Therapy of Patients With Metastatic Cancer by Radiotherapy Together With Immune Checkpoint Inhibition April 1, 2017 December 30, 2022
NCT04135313 Enrolling by invitation Phase 3 Induction and Consolidation Chemotherapy in Patients With Locally Advanced CRM-positive Rectal Cancer October 20, 2019 October 2024
NCT06429995 Enrolling by invitation Standard Follow-up Program (SFP) for Breast Cancer Patients January 1, 2008 January 1, 2030
NCT04134897 Enrolling by invitation Phase 3 Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal Cancer October 14, 2019 October 2024
NCT04103697 Enrolling by invitation Phase 3 Neoadjuvant Chemotherapy in Patients With Intermediate Risk Upper and Mid Rectal Cancer August 1, 2019 August 2024
NCT06303583 Enrolling by invitation Phase 1/Phase 2 Neoadjuvant Chemoradiotherapy Followed by Sequential Immunotherapy for Thoracic Esophageal Squamous Cell Carcinoma June 1, 2022 December 31, 2026
NCT05912205 Not yet recruiting Phase 2 Disitamab Vedotin Combined With Radiotherapy for Bladder Preservation July 1, 2023 July 1, 2026
NCT05244798 Not yet recruiting Phase 3 Sintilimab Plus NCT or NCRT Versus NCRT for ESCC November 1, 2022 December 31, 2026
NCT06345599 Not yet recruiting Phase 1/Phase 2 PRaG Therapy in Combination With Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) (NeoPRAG Study) May 1, 2024 January 10, 2027
NCT03290820 Not yet recruiting Phase 2 Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients January 1, 2018 September 30, 2024
NCT06210490 Not yet recruiting Phase 2 A Clinical Study of the Efficacy and Safety of Disitamab Vedotin in Combination With Radiotherapy for the Adjuvant Treatment of HER2 Overexpressing UTUC Patients With High Risk Factors for Recurrence After Radical Surgery January 10, 2024 May 31, 2028
NCT05433597 Not yet recruiting Phase 2/Phase 3 A Two-blinded, Multicentre, Phase II/III RCT of Concurrent Chemo-radiotherapy Combined or Not Combined With TNF as the Therapy for LA-NPC July 1, 2022 July 1, 2029
NCT05561634 Not yet recruiting Phase 2 Radiotherapy by Sonic Hedgehog Pathway Inhibitors in Basal Cell Carcinoma July 2023 July 2028
NCT06217536 Not yet recruiting Phase 1/Phase 2 Neoadjuvant Lurbinectedin and Preoperative Radiation for Treating Soft Tissue Sarcomas July 1, 2024 July 31, 2027
NCT05603013 Not yet recruiting Phase 2 Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0) October 30, 2022 October 17, 2024
NCT05665790 Not yet recruiting N/A Primary Lesion Treatment for Bone Metastases March 2023 March 2026
NCT06031597 Not yet recruiting Phase 3 Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy September 15, 2023 December 31, 2025
NCT06462079 Not yet recruiting Phase 2 Sacituzumab Govitecan Combined With Head Radiotherapy for Her2-negative Breast Cancer Brain Metastases June 15, 2024 July 15, 2027
NCT06459869 Not yet recruiting Phase 1 NG-350A Plus Chemoradiotherapy for Locally Advanced Rectal Cancer November 15, 2024 January 30, 2029
NCT06426056 Not yet recruiting Phase 2 Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: A Multicentre, Single-arm, Phase II Trial. June 2024 October 2028
NCT03358602 Not yet recruiting N/A Radiotherapy vs Neck Dissection for Clinical T1/2N0 Supraglottic Cancer December 20, 2017 November 1, 2027
NCT06304545 Not yet recruiting Phase 2 Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab March 15, 2024 March 15, 2027
NCT06035133 Not yet recruiting N/A Treatment of Low Locally Advanced Rectal Cancer With Radiotherapy Removal TNT Plus Neoadjuvant Therapy November 10, 2023 November 10, 2027
NCT06340243 Not yet recruiting Risk Adapted Therapy of Hodgkin Lymphoma in Upper Egypt April 1, 2024 April 1, 2026
NCT06353061 Not yet recruiting Phase 2 Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer April 15, 2024 February 1, 2026
NCT04127760 Not yet recruiting N/A Efficacy of Postoperative Radiotherapy for Atypical Meningioma Without Venous Sinus Invasion After Gross-total Resection January 1, 2020 January 1, 2033
NCT05690399 Not yet recruiting Evaluation of Clinical and Pathological Characteristics and Routine Treatment of Patients With Prostate Cancer January 2023 April 2024
NCT04116125 Not yet recruiting N/A Omitting Biopsy of SEntinel Lymph Node With Radiation After Neoadjuvant Chemotherapy in Breast Cancer (OBSERB) Trial July 1, 2020 June 30, 2025
NCT06128460 Not yet recruiting Phase 2 Adjuvant Chemoradiotherapy Followed by Zimberelimab for Locally Advanced Cervical Cancer. December 1, 2023 December 1, 2029
NCT05708391 Not yet recruiting Phase 2 Radiotherapy Combined With Realgar-Indigo Naturalis Formula (RIF) in the Treatment of Rhabdomyosarcoma(RMS) in Children January 31, 2023 December 30, 2024
NCT05791136 Not yet recruiting Phase 2 Immunotherapy After Radiotherapy in Elderly ESCC April 2023 June 30, 2026
NCT06409910 Not yet recruiting Phase 2 Adaptive Moderately Hypofractionated Post Operative Radiotherapy June 2024 June 2030
NCT06447454 Not yet recruiting Combining Chemoradiotherapy With Sintilimab in First-Line ICC July 1, 2024 December 31, 2028
NCT05821452 Not yet recruiting Phase 2 Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma May 25, 2023 May 30, 2026
NCT04536649 Not yet recruiting Phase 3 Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma. October 1, 2020 September 30, 2025
NCT06383663 Not yet recruiting N/A Supraclavicular Lymph Node Dissection for Ipsilateral Supraclavicular Lymph Node Metastatic Breast Cancer May 1, 2024 December 31, 2029
NCT06390982 Not yet recruiting Phase 2 Organ Preservation With Tislelizumab and Total Neoadjuvant Therapy in Patients With Low Rectal Cancer: RELIEVE -01 Study May 2024 December 2028
NCT04815616 Not yet recruiting Efficacy of Capecitabine With Adjuvant Radiotherapy in Treatment of Early Stages Breast Cancer (Retrospective Study). April 1, 2023 April 1, 2023
NCT05142982 Not yet recruiting N/A Radiotherapy vs Observation for Post Chemotherapy Residual Mass in Advanced Seminoma December 15, 2021 December 15, 2029
NCT06464614 Not yet recruiting Phase 2 Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line ESCC. July 15, 2024 August 1, 2026
NCT05574101 Recruiting Phase 2 A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer October 6, 2022 October 6, 2026
NCT00887146 Recruiting Phase 3 Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma September 2009 October 2025
NCT01212354 Recruiting Phase 3 Impact of Selective Radiation Dose Escalation and Tumour Hypoxia Status on Locoregional Tumour Control After Radiochemotherapy of HNT July 2015 September 2025
NCT01649830 Recruiting Phase 3 Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma July 2012 August 2026
NCT02105766 Recruiting Phase 2 Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure April 21, 2014 December 31, 2024
NCT02125396 Recruiting Phase 3 Adjuvant Radiotherapy Comparing TACE for Curative HCC May 1, 2019 October 2023
NCT02207465 Recruiting Phase 1 A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer July 2014 December 2025
NCT02275286 Recruiting Phase 1/Phase 2 Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients November 2014 June 2028
NCT02421718 Recruiting Standard Follow-up Program (SFP) for Lung Cancer Patients Treated With Radiotherapy or Chemoradiation March 2013 January 2028
NCT02454790 Recruiting Standard Follow-Up Program (SFP) for Patients With Esophageal Cancer September 2014 January 2030
NCT02492607 Recruiting N/A Management of Low-risk (Grade I and II) DCIS February 13, 2017 February 1, 2034
NCT02633514 Recruiting Phase 3 Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma December 1, 2023 December 2026
NCT02998385 Recruiting Phase 3 Chemo-radiotherapy Versus Radiotherapy in the Treatment of Salivary Glands and Nasal Tumors (IMRT or Protontherapy) January 20, 2017 March 2030
NCT03017053 Recruiting Phase 4 The Optimal Neck Treatments Strategy of Early Oral Cancer Based on Adverse Pathological Factor July 2016 July 2025
NCT03158090 Recruiting The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research December 15, 2017 January 30, 2051
NCT03343236 Recruiting Nutrition and Inflammation in Patients With Head and Neck Cancer November 1, 2015 December 31, 2027
NCT03474497 Recruiting Phase 1/Phase 2 UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade May 20, 2019 December 2023
NCT03495960 Recruiting Phase 2 Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous System June 15, 2019 December 31, 2024
NCT03529448 Recruiting Phase 1/Phase 2 TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma August 18, 2023 December 2025
NCT03534713 Recruiting Phase 3 Induction Chemotherapy Followed by Standard Therapy in Cervical Cancer With Aortic Lymph Node Spread July 17, 2020 December 2026
NCT03649048 Recruiting N/A Low-Dose Weekly vs High-Dose Cisplatin November 5, 2018 September 2028
NCT03650257 Recruiting Phase 2 A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96 August 21, 2019 August 20, 2024
NCT03755804 Recruiting Phase 2 Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17 December 12, 2018 July 1, 2028
NCT03774732 Recruiting Phase 3 PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer March 21, 2019 September 21, 2026
NCT03790553 Recruiting Phase 3 Comparing 61.2 Gy Radiotherapy Dose Versus 50.4 Gy Radiotherapy Dose for Locally Advanced Esophageal Carcinoma October 15, 2018 October 15, 2025
NCT03829033 Recruiting N/A Photon Therapy Versus Proton Therapy in Early Tonsil Cancer. January 22, 2019 January 2028
NCT03878342 Recruiting N/A Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast May 10, 2019 November 10, 2034
NCT03978039 Recruiting National Clinical and Biological Sarcoma Database : An Initiative of the French Sarcoma Group January 2010 December 2030
NCT04019548 Recruiting Phase 3 Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiotherapy December 16, 2019 May 1, 2030
NCT04083365 Recruiting Phase 2 Capecitabine Plus Concomitant Radiation Therapy Followed by Durvalumab as Preoperative Treatment in Rectal Cancer January 1, 2020 August 31, 2025
NCT04115267 Recruiting Attribution of Toxicities Due to Radiotherapy and Immuno-Biological Therapies September 13, 2019 September 30, 2025
NCT04221035 Recruiting Phase 3 High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN) November 5, 2019 November 2032
NCT04242589 Recruiting Phase 2 Trial of Combined Radiotherapy and Vertebroplasty for Patients With Painful Metastatic Spinal Lesions March 3, 2021 November 1, 2026
NCT04245514 Recruiting Phase 2 Multimodality Treatment in Stage III Non-small Cell Lung Cancer (NSCLC) July 15, 2020 December 2031
NCT04302454 Recruiting Phase 3 Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy March 19, 2020 December 1, 2024
NCT04319783 Recruiting Phase 2 Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA June 2, 2021 June 2026
NCT04351204 Recruiting N/A The MR-Linac Technical Feasibility Protocol January 22, 2019 July 1, 2026
NCT04365049 Recruiting Nab-Paclitaxel and Gemcitabine Plus Camrelizumab and Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma April 1, 2020 December 2023
NCT04402073 Recruiting Phase 2 Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma November 11, 2022 March 1, 2030
NCT04481763 Recruiting Phase 1/Phase 2 A Study of the Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative Breast July 14, 2020 October 1, 2026
NCT04519905 Recruiting N/A Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15) January 6, 2020 December 2027
NCT04550104 Recruiting Phase 1 A Platform Study of Novel Agents in Combination With Radiotherapy in NSCLC March 17, 2021 March 2028
NCT04557059 Recruiting Phase 3 A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer November 12, 2020 August 27, 2029
NCT04624828 Recruiting N/A Immune Response Evaluation in Oligorecurrent and Oligoprogressive Prostate Cancer Patients Treated With SBRT October 19, 2020 December 2024
NCT04625907 Recruiting Phase 1/Phase 2 FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma September 17, 2020 June 2030
NCT04648904 Recruiting Early Phase 1 Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer November 24, 2020 November 2024
NCT04698252 Recruiting Phase 2 Local Therapy for ER/PR-positive Oligometastatic Breast Cancer April 1, 2021 April 1, 2031
NCT04731610 Recruiting N/A Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma December 28, 2021 March 1, 2029
NCT04789486 Recruiting Phase 1/Phase 2 Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer May 27, 2021 September 10, 2027
NCT04807127 Recruiting A Single-cell Approach to Identify Biomarkers of Pulmonary Toxicity for Immune Checkpoint Blockade February 1, 2020 January 31, 2024
NCT04821778 Recruiting Phase 3 Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer January 1, 2002 December 31, 2025
NCT04828395 Recruiting Phase 2 Fluzoparib Combined With Camrelizumab for Maintenance Treatment of Locally Advanced Non-small Cell Lung Cancer March 1, 2021 March 1, 2025
NCT04881032 Recruiting Phase 1/Phase 2 AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma March 7, 2022 March 2027
NCT04884906 Recruiting Phase 2 Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer November 1, 2020 November 1, 2024
NCT04900623 Recruiting Phase 2 Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study July 2, 2021 June 1, 2032
NCT04958720 Recruiting Spanish Registry of Esophagogastric Cancer April 27, 2020 December 1, 2035
NCT04983095 Recruiting Phase 3 Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer October 27, 2021 December 2031
NCT04997837 Recruiting Phase 3 Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma July 21, 2021 October 21, 2027
NCT05089916 Recruiting Phase 2 Radiation During Osimertinib Treatment: a Safety and Efficacy Cohort Study January 20, 2022 December 2026
NCT05109728 Recruiting Phase 1 A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent. May 10, 2022 July 28, 2026
NCT05160727 Recruiting Phase 2 Radiotherapy Combined With Tislelizumab and Irinotecan in MSS/pMMR Recurrence and Metastatic Colorectal Cancer October 1, 2021 October 2024
NCT05192876 Recruiting Analysis of Outcomes and Adverse Events of Patients Undergoing Radiation Therapy January 1, 2000 December 31, 2025
NCT05203913 Recruiting Phase 2 Cisplatin, Nab-paclitaxel, Nivolumab With Radiotherapy After Resection of Non-Metastatic Muscle Invasive Bladder Cancer May 1, 2023 June 15, 2026
NCT05222087 Recruiting Phase 1 PRIME_LUNG: Primary Radiotherapy In MEtastatic Lung Cancer - A Pilot Study January 3, 2022 April 2024
NCT05225116 Recruiting Phase 1 Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT January 8, 2023 December 5, 2025
NCT05248633 Recruiting Phase 2 Chemotherapy Combined With Radiotherapy Versus Radiotherapy Alone for Solitary Plasmacytoma April 21, 2022 October 2026
NCT05277688 Recruiting Phase 3 Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients March 15, 2022 December 30, 2027
NCT05301881 Recruiting Phase 2 COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study April 17, 2023 April 1, 2040
NCT05305885 Recruiting N/A Intra-pemetrexed Alone or Combined With Concurrent Radiotherapy for Leptomeningeal Metastasis August 19, 2022 July 2024
NCT05334459 Recruiting Preoperative Radiotherapy and Systemic Therapy Following Surgery in 'de Novo' Metastatic Breast Cancer March 1, 2022 March 31, 2028
NCT05385926 Recruiting Phase 2 Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma May 5, 2022 April 30, 2024
NCT05394415 Recruiting Phase 1/Phase 2 Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC May 1, 2022 April 30, 2025
NCT05397262 Recruiting N/A Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia March 29, 2017 December 31, 2099
NCT05412849 Recruiting Radiation Field, Dose and Fractionation Related to Mandibular Complications January 1, 2023 July 2025
NCT05468242 Recruiting Phase 2 Study of Tislelizumab for Locally Advanced Non-Small Cell Lung Cancer Following Neoadjuvant Chemotherapy Plus Tislelizumab ± Bevacizumab and Definitive Concurrent Chemoradiation Therapy January 1, 2022 December 30, 2024
NCT05476939 Recruiting Phase 3 Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 September 29, 2022 September 2031
NCT05491317 Recruiting Phase 1/Phase 2 A Safety and Antitumor Activity Trial of Immunoradiotherapy Combinations as a Treatment Option for Subjects With Metastatic Solid Tumors March 8, 2023 July 2026
NCT05515315 Recruiting Phase 2 Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell Carcinoma May 31, 2022 May 31, 2027
NCT05515796 Recruiting Phase 2 Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors September 1, 2022 December 31, 2025
NCT05520619 Recruiting Phase 2 Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002) September 15, 2022 July 31, 2026
NCT05522582 Recruiting Phase 2 Methotrexate Combined With Immunotherapy During Radiotherapy for Solid Tumors November 15, 2021 December 31, 2024
NCT05584267 Recruiting Phase 2 Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy December 25, 2022 December 31, 2026
NCT05589701 Recruiting Comparing SBRT to CRT in Patients With Spinal Metastases December 12, 2022 December 2024
NCT05602415 Recruiting Phase 2 Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma November 2022 May 2024
NCT05635149 Recruiting Predictive Factors for Outcomes of Fruquintinib Plus Immunotherapy in Colorectal Cancer January 1, 2022 September 30, 2023
NCT05645237 Recruiting HRQOL in Prostate Cancer Patients Treated With Radiotherapy April 8, 2019 January 1, 2028
NCT05656794 Recruiting Phase 2 Consolidative Prostate Radiotherapy in Metastatic Prostate Cancer July 31, 2023 August 2031
NCT05659186 Recruiting Phase 2 PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer December 30, 2022 December 30, 2025
NCT05664464 Recruiting Phase 1/Phase 2 Glutamate Inhibitors in Glioblastoma January 1, 2023 December 2026
NCT05674305 Recruiting Phase 3 Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant Chemotherpy January 1, 2022 January 1, 2027
NCT05685004 Recruiting Phase 2/Phase 3 Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM) September 15, 2023 March 2026
NCT05713838 Recruiting Phase 2 Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery August 28, 2023 February 2027
NCT05749042 Recruiting Phase 2 A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma January 18, 2023 January 18, 2025
NCT05760391 Recruiting N/A A Study of IO Plus Radiotherapy in Patients With Advanced ESCC. February 28, 2023 August 2026
NCT05765812 Recruiting Phase 1/Phase 2 A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma May 15, 2023 September 2028
NCT05766800 Recruiting Phase 2 Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer March 14, 2023 April 1, 2027
NCT05774275 Recruiting Phase 1/Phase 2 The Combination of Radiotherapy, Chemotherapy and Immunotherapy in High-Risk Localized Soft Tissue Sarcoma August 25, 2022 August 24, 2029
NCT05790447 Recruiting Phase 2 Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors April 1, 2023 December 2025
NCT05800054 Recruiting N/A Effect of NST Whole-course Nutritional Management on Nutritional Status and Adverse Reactions in Esophageal Cancer January 1, 2021 December 31, 2027
NCT05813327 Recruiting Phase 1/Phase 2 Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma March 14, 2024 January 15, 2028
NCT05831917 Recruiting N/A MRI - Guided Adaptive RadioTHerapy for Dysphagia in Head and Neck Cancer January 17, 2023 January 1, 2026
NCT05839275 Recruiting Phase 1/Phase 2 The Combination of Radiotherapy，Surufatinib and Sintilimab in High-Risk Localized Soft Tissue Sarcoma August 1, 2022 July 31, 2029
NCT05929222 Recruiting Phase 3 Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi December 14, 2023 April 2031
NCT05950594 Recruiting Phase 2 IVIM & OLINK in Sarcoma March 5, 2024 November 30, 2026
NCT06019130 Recruiting Phase 2 Nivolumab in Children and Adults With Nasopharyngeal Carcinoma January 10, 2023 January 9, 2028
NCT06047860 Recruiting Phase 2 A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer June 16, 2023 December 31, 2024
NCT06102837 Recruiting Tumor Vaccines for Solid Tumors October 2023 October 2027
NCT06114108 Recruiting N/A Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients December 21, 2023 November 1, 2027
NCT06120374 Recruiting Adjuvant Radiotherapy and Combined Adjuvant Treatment Strategy for UTUC October 30, 2023 October 30, 2028
NCT06122493 Recruiting Phase 2 Optimization of Treatment Strategy for Unresectable cN3 Esophageal Squamous Cell Carcinoma November 1, 2022 November 1, 2026
NCT06170697 Recruiting Phase 2 Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma March 1, 2023 July 2025
NCT06173986 Recruiting Phase 1/Phase 2 Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer January 10, 2023 December 30, 2027
NCT06207981 Recruiting Phase 3 Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCA February 26, 2024 February 1, 2030
NCT06261047 Recruiting Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver Cancer January 1, 2024 January 1, 2026
NCT06281886 Recruiting Phase 2 Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma December 1, 2023 December 1, 2026
NCT06282588 Recruiting Phase 2/Phase 3 Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers December 13, 2023 December 31, 2030
NCT06285591 Recruiting N/A Lactobacillus Reuteri Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors November 10, 2023 March 31, 2025
NCT06309810 Recruiting N/A Stereotactic Radiosurgery (SRS) in Malignant Spasticity and Hypertonia March 6, 2023 August 2025
NCT06335693 Recruiting N/A Adjuvant Hypofractionated Radiotherapy for Prostate Cancer March 28, 2024 February 28, 2027
NCT06368960 Recruiting Phase 1 BM201 in Combination With Radiotherapy in Patients With Advanced Solid Tumors November 7, 2022 December 31, 2024
NCT06370663 Recruiting Phase 2 First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAIC April 1, 2024 April 1, 2026
NCT06371482 Recruiting Phase 2 Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer (Camel-01) June 1, 2023 December 31, 2027
NCT06375798 Recruiting Clinical Study of Breast Conserving Surgery Combined With Intraoperative Radiotherapy for Early Breast Cancer November 19, 2020 November 19, 2026
NCT06390176 Recruiting N/A Lactobacillus Rhamnosus GG Alleviates Oral Mucositis in Patients Undergoing Radiotherapy November 10, 2023 March 31, 2025
NCT06401447 Recruiting N/A TPF Concurrent Chemo-radiotherapy Plus Immunotherapy for Local Advanced Esophageal Squamous Cell Carcinoma December 1, 2023 December 1, 2026
NCT06402708 Recruiting Phase 3 Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3) April 9, 2024 May 1, 2030
NCT06422858 Recruiting Phase 2 Sequential Tegafur-gimeracil-oteracil Potassium Capsule (s-1) and Serplulimab Following Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma May 2024 April 2026
NCT02121405 Suspended Phase 3 Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy for Rectal Cancer With MRI Negative CRM October 2015 February 2026
NCT04084158 Suspended Phase 2 A Study of Toripalimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma. September 7, 2019 December 30, 2021
NCT00841945 Terminated Phase 3 Treatment of Aggressive Localized Lymphoma April 2005 February 2017
NCT03992326 Terminated Phase 1 Adoptive Transfer Of Autologous Tumor-Infiltrating Lymphocytes in Solid Tumors September 1, 2019 March 5, 2021
NCT00581113 Terminated Phase 3 Neural Stem Cell Preserving Brain Radiation Therapy & Stereotactic Radiosurgery in Patients With 1-6 Brain Metastases March 2007 June 2009
NCT00417248 Terminated Phase 1/Phase 2 Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer June 2007 April 2008
NCT01525927 Terminated Phase 2 Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity August 2010 December 2011
NCT01759238 Terminated Phase 2 Chemoradiotherapy for Patients With Oligometastatic Colorectal Cancer May 2013 October 2014
NCT00310050 Terminated Phase 1 Pemetrexed, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer October 2005 May 2008
NCT00551759 Terminated Phase 2 Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer October 2, 2008 February 2014
NCT00916045 Terminated Phase 2 Pilot Study of Unrelated Cord Blood Transplantation September 2009 March 2012
NCT00271323 Terminated Phase 2 Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients May 2005 February 2007
NCT00434941 Terminated Phase 2 Capecitabine Plus Radiotherapy for Local Relapse Breast Cancer With Negative Her2 Tumours September 2007 January 2009
NCT01843452 Terminated Phase 2 Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal December 2012 May 2016
NCT03970694 Terminated Phase 3 Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy For Unresectable Locally Advanced Colon Cancer May 11, 2019 June 5, 2022
NCT00460551 Terminated Phase 2 Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer April 2007 October 2008
NCT02562625 Terminated Phase 2 Trial of Pembrolizumab and Radiotherapy in Melanoma February 2016 March 2020
NCT00455572 Terminated Phase 1 Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer May 11, 2007 August 8, 2013
NCT02910843 Terminated Phase 1 Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer February 22, 2017 December 31, 2021
NCT02901483 Terminated Phase 1/Phase 2 A Study of PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck Cancer October 11, 2016 August 17, 2020
NCT00542191 Terminated Phase 2 Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer July 2007 August 2, 2016
NCT01868906 Terminated Phase 2 FMISO-PET in Brain Tumors and SCS Effect June 2013 September 17, 2017
NCT00401401 Terminated Phase 1/Phase 2 Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer December 2006 October 2010
NCT03394716 Terminated Monitoring MRI Changes Before and During Radiotherapy Treatment of Brain Tumors January 12, 2018 December 10, 2020
NCT00870701 Terminated Phase 3 Observation Versus Post-surgery Radiotherapy After Complete Exeresis in Soft Tissues Members Sarcoma March 19, 2009 March 10, 2017
NCT02956889 Terminated Phase 2 To Assess The Efficacy And Safety Of Vismodegib And Radiotherapy In Advanced Basal Cell Carcinoma October 2016 January 2020
NCT02520479 Terminated Phase 2 "Sandwich" Chemotherapy With Radiotherapy in Newly Diagnosed, Stage IE to IIE, ENKTL June 2013 January 2018
NCT01507506 Terminated Phase 3 Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma March 15, 2011 January 2, 2020
NCT04653389 Terminated Phase 2 Perioperative Therapy for Hepatocellular Carcinoma December 26, 2020 December 1, 2021
NCT00449657 Terminated Phase 2 Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLC February 2007 August 22, 2017
NCT02473094 Terminated Phase 2 Neoadjuvant Metformin in Association to Chemoradiotherapy for Locally Advanced Rectal Cancer July 2015 February 2016
NCT02465593 Terminated Phase 1/Phase 2 A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer June 2015 July 28, 2021
NCT00745797 Terminated Phase 3 Prophylactic Cranial Irradiation (PCI) Versus no PCI in Non Small Cell Lung Cancer After a Response to Chemotherapy April 2008 August 2012
NCT02819752 Terminated Phase 1 PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck July 12, 2017 November 28, 2019
NCT02439008 Terminated N/A Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response September 16, 2015 March 18, 2019
NCT00226941 Terminated Phase 1/Phase 2 A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer June 2004 February 2009
NCT02412371 Terminated Phase 1/Phase 2 A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Adults With Stage III Non-Small Cell Lung Cancer (NSCLC) April 30, 2015 August 5, 2019
NCT04473937 Terminated N/A Radiation Post-CAR T in Refractory Lymphoma January 5, 2021 July 3, 2023
NCT02376933 Terminated N/A Vertebral Augmentation and Radiotherapy of Collapse Spinal Metastatic Cancer August 20, 2013 April 7, 2017
NCT00494026 Terminated Phase 2 Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC) September 2007 October 2008
NCT01557114 Terminated Phase 1 Study of Radiotherapy Administered in Combination With Ipilimumab in Patients With Unresectable Stage III or Stage IV Advanced Malignant Melanoma March 2011 March 2016
NCT02329795 Terminated Image-derived Prediction of Response to Chemo-radiation in Glioblastoma October 2014 October 2016
NCT02285543 Terminated Phase 2 A Phase II Trial of TPF Induction Chemotherapy in cN2 OSCC Patients December 1, 2016 July 30, 2023
NCT02236936 Terminated Phase 3 Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck February 3, 2017 July 10, 2019
NCT00421096 Terminated Phase 2 Radiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine in Uterine Cervical Cancer May 2005 December 2011
NCT02183246 Terminated Phase 3 Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients May 2000
NCT01375023 Terminated Phase 2 Allogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast Cancer June 2009 December 2013
NCT01372202 Terminated Phase 2 CHFR Methylation Status Esophageal Cancer Study June 2011 October 1, 2014
NCT00402883 Terminated Phase 2 Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer November 2006 January 2009
NCT03644823 Terminated Phase 2 Combinatory ImmunoTherapy-1 (Com-IT-1) Irradiation and PD-1 Blockade in Locally Advanced / Advanced NSCLC August 15, 2018 December 31, 2020
NCT02745587 Terminated Phase 3 Evaluating the Impact of Prostate Only Versus Pelvic Radiation for N+ Prostate Cancer. April 1, 2016 September 22, 2022
NCT00895245 Terminated Phase 2 Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy February 2009 February 2011
NCT03763851 Terminated Phase 2 Cannabis Oil and Radiation Therapy for the Management of Pain March 14, 2018 November 30, 2018
NCT00937612 Terminated N/A Postoperative Concurrent Chemoradiation for Head and Neck Cancer With Multiple Minor Risk June 2008 March 2014
NCT02010567 Terminated Phase 1/Phase 2 Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer December 2013 June 25, 2019
NCT01531712 Terminated Phase 2 Study of Neoadjuvant Treatment in Patients With Pancreatic Cancer That is Potentially Resectable February 10, 2011 December 2012
NCT01666600 Terminated Phase 1/Phase 2 NOA-12: BIBF1120 and R-RT in Glioblastoma August 2012 September 2017
NCT00859495 Terminated Phase 2 Trimodal Lung-Sparing Treatment of Pleural Mesothelioma February 2008 February 2012
NCT03763422 Terminated Phase 3 Trial in Low Grade Glioma Patients: Wait or Treat March 16, 2020 December 29, 2021
NCT01011842 Terminated N/A Real-Time kV Imaging vs. Real-Time 3D Patient Surface Tracking for Head & Neck Cancer October 2009 November 2011
NCT02603159 Unknown status Phase 3 Different Cycles of Capecitabine Usage in Esophageal Cancer Concurrent Chemoradiotherapy October 2014 December 2019
NCT03344068 Unknown status Phase 2/Phase 3 Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal Carcinoma January 1, 2018 March 31, 2021
NCT02580929 Unknown status N/A Clinical Study of Effectiveness of Radiotherapy Before Surgery in High-risk Relapse Hepatocellular Cancer Patients October 2014 July 2017
NCT03349866 Unknown status Phase 2 A Prospective Study of Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy for Siewert II ，III of Locally Advanced HER-2 Negative Adenocarcinoma at Gastroesophageal Junction November 30, 2017 November 30, 2020
NCT02560636 Unknown status Phase 1 Pembrolizumab in Muscle Invasive/Metastatic Bladder Cancer June 2016 June 2024
NCT03368131 Unknown status Phase 2 Concurrent Neoadjuvant Chemoradiotherapy Plus Trastuzumab in the Treatment of Siewert II ，III of Human Epidermal Growth Factor Receptor-2(HER-2) Positive Gastroesophageal Junction Adenocarcinoma： A Randomized, Controlled Clinical Study December 1, 2017 December 31, 2020
NCT02549261 Unknown status N/A Nimotuzumab in Combination With Radiochemotherapy for Patients With Stage IIIA/IIIB Non-small Cell Lung Cancer March 2011 December 2015
NCT02526953 Unknown status Phase 3 Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients January 2016 October 2022
NCT03416803 Unknown status N/A A Study of Individualized Radiotherapy Based on a Prediction Model of Lymph Node Metastasis in Hepatocellular Carcinoma February 2018 June 30, 2020
NCT02480634 Unknown status Phase 4 Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer June 2019 December 2022
NCT05091814 Unknown status Prevalence of Trismus in Patients With Maxillary Cancer With and Without Radiation Therapy in the Egyptian Population. December 2021 December 2022
NCT00896155 Unknown status Phase 3 Trial of Concurrent Versus Sequential Tamoxifen With Radiotherapy in Breast Cancer Patients December 2008 December 2013
NCT03520257 Unknown status Phase 2 The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus May 1, 2018 June 30, 2019
NCT01117402 Unknown status Phase 2 Tomotherapy in Postsurgery Recurrent Carcinoma Cervix December 2008 December 2014
NCT02409186 Unknown status Phase 3 A Phase III Study of Nimotuzumab Plus Concurrent Chemoradiotherapy in Loco-regional Esophageal Squamous Cell Carcinoma March 2015 December 2021
NCT03553485 Unknown status N/A Effects of VNS on RT-induced Inflammation and Prognosis of Patients With NSCLC August 8, 2018 December 2019
NCT03561142 Unknown status Phase 2 Organ Preservation in Locally Advanced Rectal Cancer by Radiochemotherapy Followed by Consolidation Chemotherapy. June 15, 2018 April 16, 2024
NCT02202928 Unknown status Phase 2 Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer July 2014 December 2017
NCT03614065 Unknown status Phase 2 Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC February 21, 2017 November 2018
NCT02145494 Unknown status Phase 2 The SPARC Trial: Stereotactic Prostate Ablative Radiotherapy Using Cyberknife June 2013 December 2018
NCT00597311 Unknown status Phase 3 Preoperative Chemoradiation Versus Short Term Radiation Alone With Delayed Surgery for Stage II and III Resectable Rectal Cancer January 2007 January 2012
NCT02014805 Unknown status Phase 3 Postoperative Conformal Radiotherapy for Stage II-III B Type Thymoma July 2013 July 2022
NCT03702179 Unknown status Phase 2 Durvalumab Plus Tremelimumab With Concurrent Radiotherapy for Localized Muscle Invasive Bladder Cancer Treated With a Selective Bladder Preservation Approach November 19, 2018 December 2022
NCT03732482 Unknown status Phase 2/Phase 3 Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain Metastases March 1, 2019 May 30, 2022
NCT00894153 Unknown status Phase 4 p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage May 2009 June 2013
NCT01647555 Unknown status Radiotherapy in Association With Cetuximab in Patients Treated for an Epidermoid Cancer November 2006 December 2014
NCT04189094 Unknown status Phase 2 Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC January 1, 2020 July 1, 2023
NCT01643070 Unknown status Phase 2 Preoperative CRT With or Without Induction Chemotherapy for Rectal Cancer With Liver Metastases January 2010 December 2016
NCT01576796 Unknown status Phase 2 Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer March 2012 June 2017
NCT00394628 Unknown status Phase 1/Phase 2 AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme October 2006
NCT01567202 Unknown status Phase 2 Study of DC Vaccination Against Glioblastoma March 2012 February 1, 2021
NCT04267146 Unknown status Phase 1/Phase 2 Nivolumab in Combination With Temozolomide and Radiotherapy in Children and Adolescents With Newly Diagnosed High-grade Glioma July 15, 2019 January 2024
NCT04278287 Unknown status Phase 1/Phase 2 Chemoradiotherapy in Unresectable Esophageal Cancer October 1, 2019 September 2022
NCT04282122 Unknown status Clinical Database of Safe Personalized Adjuvant Breast Radiotherapy Based on Individual Radiosensitivity May 23, 2019 June 2024
NCT04333927 Unknown status Phase 2 Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder Cancer June 1, 2020 June 2024
NCT00999700 Unknown status Phase 3 Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus Cisplatin September 2009 December 2021
NCT04404491 Unknown status Phase 3 Clinical Control Study of Immunotherapy and Concurrent Chemoradiotherapy in Patients With Esophageal Cancer Recurrence June 1, 2020 June 30, 2023
NCT04420390 Unknown status N/A Low Dose Radiotherapy for COVID-19 Pneumonitis May 1, 2020 September 8, 2020
NCT00982436 Unknown status Phase 1/Phase 2 Neoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck Cancer September 2009 December 2012
NCT01501136 Unknown status Phase 4 Treatment of Natural Killer/T Cell Lymphoma-I/II January 2011 May 2019
NCT04513301 Unknown status Phase 2 Efficacy and Safety of Sintilimab With or Without Radiotherapy in Patients With Recurrent or IV NSCLC (EGFR -, ALK -) After Failure of Platinum-based Chemotherapy: A Randomized,Open Labled, Phase II Clinical Study January 1, 2020 December 1, 2022
NCT00420394 Unknown status Phase 2 Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer April 2007
NCT01474187 Unknown status Phase 1 Genotype-driven Phase I Study of Irinotecan Administered in Neoadjuvant Chemoradiotherapy in Patients With Stage II/III Rectal Cancer November 2011 December 2012
NCT01472653 Unknown status Phase 2 Treatment Selection According to Skin Reaction to Cetuximab December 2011 December 2016
NCT04569916 Unknown status Phase 2 Radiotherapy Combined With Irinotecan and Apatinib Followed by PD-1 Antibody and Apatinib for Advanced Solid Tumors September 2020 May 2023
NCT01459328 Unknown status Phase 3 Resource-Sparing Curative Treatment for Rectal Cancer September 2009
NCT00497588 Unknown status Phase 3 the Comparison of Voice Quality in Early Laryngeal Cancer Between Surgery and Radiotherapy March 2007 April 2014
NCT01452672 Unknown status Phase 3 Resource-sparing Post-mastectomy Radiotherapy in Breast Cancer March 2007 December 2012
NCT00753727 Unknown status Phase 1/Phase 2 Sunitinib and Radiation in Patients With Resectable Soft-tissue Sarcoma September 2008 March 2016
NCT01402193 Unknown status Phase 3 Study of Arimidex and Radiotherapy Sequencing July 2011 July 2015
NCT04735939 Unknown status Chronotherapy for Radiotherapy of Glioma February 1, 2021 December 31, 2021
NCT04741490 Unknown status N/A Camrelizumab Combined With Radiotherapy for Adjuvant Treatment of Esophageal Squamous Cell Carcinoma After Surgery February 2021 August 2023
NCT04810663 Unknown status Outcome of Radiation Therapy in Operated Gastric Cancer April 1, 2021 April 1, 2023
NCT01368419 Unknown status Phase 2 Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients May 2011 May 2013
NCT04815629 Unknown status Outcome of Radiation Therapy in Urinary Bladder Squampus Cell Carcinoma April 1, 2022 April 1, 2023
NCT04815642 Unknown status Hypofractionated Radiotherapy Concomitantly With Weekly Boost for Breast Cancer Patients Treated With Conservative Breast Surgery December 1, 2021 April 1, 2023
NCT04851132 Unknown status N/A Radiotherapy Plus Durvalumab in Elderly Esophageal Squamous Cell Carcinoma March 11, 2021 June 2023
NCT04866836 Unknown status Phase 2 A Study of Tislelizumab Combined With Radiotherapy as the Second-line Treatment of Advanced Biliary Malignant Tumors October 1, 2020 October 1, 2022
NCT04873440 Unknown status Phase 1/Phase 2 An Open-label, Phase I/II Study of Manganese Plus Radiotherapy in Patients With Metastatic Solid Tumors or Lymphoma May 6, 2021 May 31, 2023
NCT00690963 Unknown status Phase 1/Phase 2 Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory Gating September 2008 October 2016
NCT00686114 Unknown status Phase 3 Concurrent Chemoradiotherapy Containing Paclitaxel&Cisplatin With/Without Tarceva in Locally Advanced Esophageal Cancer May 2008 December 2014
NCT02938195 Unknown status Phase 2 Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal Cancer January 2016 January 2018
NCT02887313 Unknown status Phase 2 FOLFOX6 Totally Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer: A Real World Study July 2016 August 2020
NCT02974127 Unknown status Multisession Radiosurgery in Large Meningiomas August 2011 April 2021
NCT02985255 Unknown status Phase 2 Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral Tongue April 2016 June 2017
NCT02883543 Unknown status Phase 3 First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation June 2016 June 2019
NCT01232374 Unknown status Phase 2 Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma September 2010 January 2016
NCT03022734 Unknown status Phase 2 Short Course Radiotherapy, Unresectable Rectal Cancer, Liver Metastasis September 2016 June 2021
NCT02812654 Unknown status Phase 2 Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment March 2015 March 2019
NCT02784015 Unknown status Phase 2 Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma May 2016 May 2023
NCT02771743 Unknown status Phase 2 Response-based Treatment of High-risk Neuroblastoma April 2015 March 2023
NCT02766270 Unknown status Early Phase 1 CCRT With Temozolomide Versus RT Alone in Patients With IDH Wild-type/TERT Promoter Mutation Grade II/III Gliomas September 26, 2016 December 2018
NCT02745561 Unknown status Phase 2 Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients. January 2016 December 2018
NCT05033587 Unknown status Phase 2 Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma. September 2021 November 1, 2023
NCT02741856 Unknown status Phase 2/Phase 3 Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation November 4, 2016 April 2023
NCT02738983 Unknown status Phase 2 RT Plus EGFR-TKI for Wild-type NSCLC January 2012 December 2017
NCT03199807 Unknown status Phase 1/Phase 2 Phase IB/II Study of NRT Combined With Radiotherapy for Advanced HCC July 20, 2017 July 20, 2021
NCT02705183 Unknown status N/A Post-operative RadioTherapy for Patients With Metastases of the Long Bones January 2016 January 2019
NCT03254511 Unknown status Phase 2 Addition of Enoxaparin to Neoadjuvant Chemoradiation of Esophageal Cancer July 22, 2016 December 30, 2018
NCT02690636 Unknown status Phase 3 Conventional Versus Hypofractionated Radiotherapy in Node Positive Breast Cancer January 2016 April 2021
NCT02674646 Unknown status Phase 2 RandOmized Study Exploring the Combination of radioTherapy With Two Types of Acupuncture Treatment: The ROSETTA Trial February 2016 February 2018
NCT02633176 Unknown status Phase 3 Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma January 2015
NCT02631239 Unknown status Phase 3 MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma March 16, 2016 July 17, 2022
NCT02607540 Unknown status Phase 3 Different Cycles of Cisplatin-5-fluorouracil for the Chemoradiotherapy of Esophageal Squamous Cancer October 2014 December 2020
NCT02604615 Unknown status Phase 3 The Role of Different Cycles of Chemotherapy（Capecitabine-oxaliplatin） in Esophageal Chemoradiotherapy October 2014 December 2020
NCT01843829 Unknown status Phase 2 A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer October 2013 May 2016
NCT01024829 Unknown status N/A Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using FDG-PET-CT Scan in Stage IB, II and III NSCLC May 2010 March 2022
NCT01843049 Unknown status Phase 1/Phase 2 Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal Cancer January 2013
NCT01756170 Unknown status Phase 3 Postoperative Chemoradiation v.s Radiotherapy for Lymph Node Negative Cervical Cancer Patients January 2011 December 2016
NCT04104074 Unknown status Phase 1 Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor Thrombosis November 25, 2019 December 31, 2021
NCT05282784 Unknown status N/A Hyperthermia With Flexible Electrode-typed 2-MHz Device During Radiotherapy for Solid Tumors March 10, 2022 April 30, 2022
NCT01755845 Unknown status Phase 3 Trial of Postoperative Chemoradiotherapy With or Without Consolidation Chemotherapy for Cervical Cancer Patients January 2011 December 2016
NCT01735747 Unknown status Phase 2 Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma June 2008 November 2013
NCT01732380 Unknown status Phase 2 A Phase-II Study Of Raltitrexed/Oxaliplatin Plus Radiotherapy Versus Radiotherapy In Subjects With Inoperable Esophageal Cancer July 2012 July 2013
NCT04121975 Unknown status Phase 2 CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer August 1, 2019 August 2022
NCT01716949 Unknown status Phase 1/Phase 2 Neoadjuvant Chemoradiation With 5-FU(or Capecitabine) and Oxaliplatin Combined With Hyperthermia in Rectal Cancer September 2012 June 2023
NCT04138992 Unknown status Phase 2/Phase 3 A Study on the Efficacy and Safety of Bevacizumab in Untreated Patients With Locally Advanced Cervical Cancer August 1, 2020 May 31, 2022
NCT03771625 Unknown status Evaluating Structural and Functional Changes of Brain by fMRI and DTI in Patients With Intracranial Germ Cell Tumors June 1, 2019 November 1, 2021
NCT01999998 Unknown status N/A FDG PET-CT for Lymphoma Radiotherapy Planning Version 1.3 August 2013
NCT03780569 Unknown status N/A TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM April 27, 2017 January 2019
NCT01973101 Unknown status Phase 2 Non-comparative Study of Treatment With Induction Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation or Definitive Chemoradiation in Invasive Locally Advanced Carcinomas of Uterine Cervix. June 2012 April 2017
NCT01064999 Unknown status Phase 2/Phase 3 A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer March 2010 December 2014
NCT03823079 Unknown status Phase 2 Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia February 1, 2019 February 1, 2020
NCT01034189 Unknown status Phase 2 Cetuximab/Paclitaxel/Cisplatin Concurrent Chemoradiotherapy Followed by Esophagectomy for Loco-regional Esophageal Cancer October 2008 June 2012
NCT01914289 Unknown status N/A Prognosis of Resection and Radiotherapy in the Treatment of Intrahepatic Cholangiocarcinoma Patients January 2011 April 2016
NCT03950362 Unknown status Phase 2 Bladder PREserVation by RadioTherapy and Immunotherapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer June 15, 2020 June 15, 2024
NCT01880359 Unknown status Phase 3 AF CRT +/- Nimorazole in HNSCC July 25, 2014 January 9, 2023
NCT03673735 Withdrawn Phase 3 Maintenance Immune Check-point Inhibitor Following Post-operative Chemo-radiation in Subjects With HPV-negative HNSCC June 2021 December 2027
NCT00233636 Withdrawn Phase 2 Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck July 2003
NCT02054559 Withdrawn Phase 3 R-CHOP Alone vs. R-CHOP Plus Radiotherapy for Localized CD20+ DLBCL January 2020
NCT02542930 Withdrawn Phase 2 Abscopal Effect for Metastatic Non-small Cell Lung Cancer. January 2016 December 2019
NCT00918593 Withdrawn Phase 2 Palliative Treatment of Ulcerated Cutaneous Metastases: Trial Between Electrochemotherapy and Radiotherapy December 2009 February 2014
NCT02598687 Withdrawn Phase 1 Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer. December 2015 April 2016
NCT05481775 Withdrawn Phase 2 Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer April 1, 2022 September 30, 2025
NCT03245177 Withdrawn Phase 1 Pembrolizumab in Combination With Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) August 2017 August 1, 2019
NCT02542137 Withdrawn Phase 2 Abscopal Effect for Metastatic Small Cell Lung Cancer September 2015 December 2019
NCT02716688 Withdrawn Phase 2 S-1 and Radiotherapy for Elderly Esophageal Cancer Patients January 2016 December 2020
NCT01295099 Withdrawn Phase 4 Keloid Scarring: Treatment and Pathophysiology
NCT04203511 Withdrawn Phase 3 INCMGA00012 in Combination With Chemoradiation in Participants With Stage III Non-Small Cell Lung Cancer (POD1UM-301) July 31, 2020 January 31, 2025